#USA #New York #Health Innovation #Leap Health #infusion therapy

Leap Health: A New Era in Infusion Therapy

The landscape of infusion therapy is rapidly evolving, particularly with the rise of at-home care options. Leap Health, a pioneering player in this field, is at the forefront of this change, promising substantial savings and enhanced patient experiences.

The Surge in Infusion Therapy Market

The U.S. infusion therapy market has seen remarkable growth, escalating from $150 billion in 2015 to a projected $360 billion by 2025. This increase is mainly driven by a growing population suffering from chronic and complex health conditions. Additionally, the annual introduction of 10 to 20 new FDA-approved infusion medications exacerbates the demand for innovative treatment models. Despite this growth, traditional care settings still dominate, with a staggering 85% of infusions taking place in hospitals. These facilities are often marked by high costs, limited flexibility, and health risks for patients undergoing treatment.

The Financial Burden

The financial implications are significant. Data shows that a mere 2% of employees requiring infusion therapy account for over half of specialty drug costs, presenting a hidden challenge in employer-sponsored health insurances. This reality calls for an innovative approach that minimizes these expenses while improving patient care.

Leap Health's Innovative Approach

Leap Health has embarked on a mission to redefine infusion therapy by introducing a platform that emphasizes at-home care along with transparent, pass-through pricing. The platform enables employers, health managers, and health plans to drastically reduce expenses while simultaneously enhancing patient satisfaction. An impressive feature of Leap Health's model is that it charges no markup on drug prices and provides clear fee-for-service billing, allowing employers to save up to 40% per infusion treatment. This shift can lead to overall cost reductions of up to 50% by moving treatments from pricey hospitals to more affordable environments.

Key Benefits of Leap Health's Model

• - In-Home Care vs. Center-Based Services: Patients can receive treatments in their own homes or at nearby partner facilities. This flexibility reduces work interruptions, enhances convenience, and supports better adherence to treatment plans.
• - Transparent Pricing: By eliminating provider markups and basing prices on actual acquisition costs, Leap Health ensures that employers maximize the benefits from pharmaceutical supply chain efficiencies.
• - Flexible Scheduling: Appointments are tailored to fit the availability of employees, easing the burden of time off work, and fostering greater accessibility to care.
• - Enhanced Patient Experience: With 98% of patients expressing higher satisfaction levels, at-home infusions lead to better treatment adherence and improved health outcomes.
• - Comprehensive Clinical Support: Leap Health oversees everything from clinical management to scheduling and drug acquisition, ensuring a seamless infusion experience.

Strategic Partnerships and Growth

In pursuit of expansion, Leap Health has established partnerships with prominent healthcare providers and several self-insured employers, extending its reach to more than 2 million potential patients in 2025. By advancing these collaborations, Leap Health delivers its vital infusion services to thousands across the country, facilitating significant cost transformations.

Proven Results

Employers utilizing Leap's services have reported transformative benefits:

• - Optimized Care Settings: A shift away from traditional hospital environments has resulted in hundreds of thousands of dollars in savings for high-cost patients.
• - Significant Drug Cost Reductions: Leap Health delivers average savings of approximately $5 million per 10,000 eligible members for large organizations, enhancing budget management.
• - Extensive Clinical Network: Leap's network of nurses and care coordinators are strategically placed to ensure that all claims can be covered nationally, ensuring continuity of care.

Vision from the Top

Rob LaHayne, CEO of Leap Health, emphasizes the necessity for transformation in infusion therapy, stating, "Infusion therapy is one of the most opaque and costly aspects of modern healthcare. We built Leap to shed light on this hidden cost and provide a smarter, more humane solution for employers and patients alike. Our approach, focusing on site-of-care optimization and pricing transparency, is leading to a far more effective and patient-centered experience in infusion therapy."

Conclusion

Leap Health is fundamentally altering the narrative surrounding infusion therapy, emphasizing accessibility, savings, and an overall enhanced patient journey. By streamlining processes and focusing on what truly matters—patient care and cost-efficiency—Leap Health is poised to make significant waves in the future of healthcare delivery.